The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles
- 1 January 1989
- journal article
- clinical trial
- Published by Springer Nature in Archiv für Gynäkologie
- Vol. 246 (S1) , S45-S52
- https://doi.org/10.1007/bf00935852
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitmentFertility and Sterility, 1988
- Short-term use of gonadotropin-releasing hormone agonist (Leuprolide) for in vitro fertilizationJournal of Assisted Reproduction and Genetics, 1988
- Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulationFertility and Sterility, 1988
- An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analogFertility and Sterility, 1988
- STIMULATION OF LH FRAGMENTS WITH REDUCED BIOACTIVITY FOLLOWING GnRH AGONIST ADMINISTRATION IN WOMENJournal of Clinical Endocrinology & Metabolism, 1984
- The Neuroendocrine Control of the Menstrual CyclePublished by Elsevier ,1980